✦ LIBER ✦

Leflunomide-induced polymyositis in a patient with rheumatoid arthritis

✍ Scribed by Sae Ochi; Ken Taniguchi; Masakazu Nagashima

Publisher: Springer
Year: 2009
Tongue: English
Weight: 255 KB
Volume: 19
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-009-0181-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

D-penicillamine–induced polymyositis in

D-penicillamine–induced polymyositis in patients with rheumatoid arthritis

✍ Koki Takahashi; Tadaatsu Ogita; Hirokazu Okudaira; Sadayoshi Yoshinoya; Hisayosh 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB 👁 2 views

Life-threatening hypertriglyceridemia du

Life-threatening hypertriglyceridemia during leflunomide therapy in a patient with rheumatoid arthritis

✍ F. Laborde; D. Loeuille; I. Chary-Valckenaere 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Pancytopenia, including macrocytic anemi

Pancytopenia, including macrocytic anemia, associated with leflunomide in a rheumatoid arthritis patient

✍ Yasuhiko Toyokawa; Isamu Kingetsu; Chiho Yasuda; Jun Yasuda; Ken Yoshida; Daitar 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 490 KB

Antiphospholipid and antisynthetase synd

Antiphospholipid and antisynthetase syndrome in a patient with polymyositis–rheumatoid arthritis overlap

✍ Andrea Ponyi; Tamás Constantin; Katalin Dankó 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 159 KB

Leflunomide-related lung injury in patie

✍ Fumikazu Sakai; Satoshi Noma; Yasuyuki Kurihara; Hidehiro Yamada; Arata Azuma; S 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 331 KB

Treatment with leflunomide slows radiogr

Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis

✍ John T. Sharp; Vibeke Strand; Hoi Leung; Frank Hurley; Iris Loew-Friedrich 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 692 KB

## Objective: To determine whether treatment with leflunomide (lef), methotrexate (mtx), or sulfasalazine (ssz) for 6-12 months retards progression of radiographic damage and to identify clinical variables that correlate with radiographic progression. ## Methods: Radiographs of the hands and feet